Baylor College of Medicine

A Study to Evaluate Ecopipam Tablets in Children and Adolescents with Tourette's Syndrome (H-46357)

Description

Content

A Multicenter, Open-Label, Extension Study Intended to Evaluate the Long-Term Safety of Ecopipam Tablets in Children and Adolescents Subjects with Tourette's Syndrome

This research study is from Emalex Biosciences, Inc. and involves an investigational drug called ecopipam as a possible treatment for Tourette's syndrome (TS).   

This is an open-label extension research study of H-46054 and is closed for enrollment.  

Contact

Rory Mahabir

Phone 1: 713–798–5989

IRB: H-46357

Status:

Active

Created:

Back to topback-to-top